HLS Therapeutics Stock (OTC: HLTRF) stock price, news, charts, stock research, profile.
You can purchase shares of HLS Therapeutics (OTCPK:HLTRF) through any online brokerage.
There are no as such competitors for HLS Therapeutics.
HLS Therapeutics has a consensus price target of $5.00.
The stock price for HLS Therapeutics (OTCPK: HLTRF) is $2.385 last updated November 13, 2024 at 2:28 PM EST.
A quarterly cash dividend of 0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 14, 2018 to stockholders of record on October 23, 2018.
HLS Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for HLS Therapeutics.
HLS Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.